Learn from supply chain experts how IRT helps them streamline increasingly complex workflows
Early phase oncology supply can present a number of complexities. What are some ways that sponsors can reduce complexity and manage these challenges? How can they optimize their supply chain and maintain flexibility in trials for such pivotal early phase studies?
In this panel discussion, Bryan O'Neill, Daichii-Sankyo, and Kim Davis, Corcept Therapeutics discuss how they are able to manage through a number of difficult scenarios in small sample size trials with cutting-edge clinical software.
What You Will Learn
Published March 2021